NDC Compounded Drug 69194-553-01 Moxifloxacin Hydrochloride

Injection Intraocular

Table of Contents

    1. Compounded Product Information
    2. NDC Crossover Products Matching 553 Moxifloxacin 150mcg/0.1ml Syringe
    3. Frequently Asked Questions

Compounded Drug Product Information

NDC Product Code 69194-553
NDC Package Code 69194-553-01
11-Digit NDC Billing Format NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.		 69194055301
Package Description .4 mL in 1 SYRINGE
Product Type What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.		 Human Compounded Drug
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.		 553 Moxifloxacin 150mcg/0.1ml Syringe
Non-Proprietary Name What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.		 Moxifloxacin
Substance Name What is the Substance Name?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.		 Moxifloxacin Hydrochloride
Dosage Form Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Route Name Intraocular - Administration within the eye.
Marketing Category OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Code 69194
Labeler Name What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.		 Pine Pharmaceuticals Llc
Substance Name Moxifloxacin Hydrochloride
Active Ingredients Information 150 ug/.1 mL
Reporting Period 2024-2

NDC Crossover Products Matching Moxifloxacin Hydrochloride

NDC crossover of 553 Moxifloxacin 150mcg/0.1ml Syringe with NDC 69194-553 a human compounded drug with other similar products matching the same substance name (Moxifloxacin Hydrochloride) and the same administration route (intraocular) or dosage form (injection).

Frequently Asked Questions

What is the NDC number assigned to Moxifloxacin Hcl?

Moxifloxacin Hcl was assigned by its manufacturer with NDC product code 69194-553. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.

Which are the NDC package codes for Moxifloxacin Hcl?

The NDC package code 69194-553-01 was assigned to a .4 mL in 1 SYRINGE of moxifloxacin hydrochloride administered intraocular via injection.

Who manufactures this product?

Moxifloxacin Hcl is manufactured by an outsourced facility and labeled by Pine Pharmaceuticals Llc. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.

Which are the NDC crossover matchings for this product?

We found 12 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Pine Pharmaceuticals LLC and Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories with NDC product codes 69194-129-01, 69194-130-01, 69194-585-01, 69194-585-01, 71266-8604-1, 71266-8604-1, 71266-8604-1, 71266-8604-1, 71266-8613-1, 71266-8613-1, 71266-8613-1 and 71266-8613-1.